Here again, the use of TTX (30 μM in order to inhibit >70% of sodium current) or siRNA specifically targeting NaV1.5 expression, induced a significant reduction of cancer cell invasiveness, by approximately 50%, compared with untreated or non-sense control siRNA-treated cells. Here, SCN5A is linked to cancer.